DHSC_DfL Kansalliset MedTech-tuotteiden vähennys- ja uudelleenkäyttökampanjat 2026

The Department of Health and Social Care, working jointly with the Greener NHS team in NHS England, is seeking to appoint a supplier to provide research, analysis, piloting, implementation evaluation and programme support for the Design for Life National Reuse and Reduce MedTech Products Programme. The programme supports the Government’s ambition to deliver a circular economy for MedTech products by 2045. The supplier will support selected circular MedTech product initiatives and associated interventions as they move through investigation, piloting, implementation and, where appropriate, wider national rollout. Scope of the requirement 1. recruit, mobilise, brief and support a minimum of 20 NHS Trusts to participate in pilot and implementation activity for priority circular MedTech products, with the ability to accommodate a higher number where required and agreed with the Authority; 2. provide participating organisations with support throughout the development, running and monitoring of pilots, investigations or implementation activity, including conducting quality improvement assessments and capturing relevant data; 3. undertake quality, equality, patient impact, benefits, sustainability, social value and health economic assessments using appropriate recognised methodologies; 4. carry out behavioural insight and adoption assessment work, including identifying barriers and enablers across clinical, estates, commercial, infection prevention and control, and leadership teams; and 5. develop adoption metrics, evidence reports, evaluations and lessons learned, implementation guidance, toolkits, options appraisals and recommendations to inform future campaigns and potential national rollout. The initial requirement comprises two projects: pilot and implementation evaluation support for selected priority products, and investigation and evidence development for two future priority product areas selected from the areas set out in the specification and agreed with the Authority. The initial products are expected to include tourniquets, blood pressure cuffs, theatre caps, sharps bins, non-sterile gloves, couch roll and pulp products. DHSC is particularly interested in suppliers, including consortia or subcontracting arrangements where appropriate, with multidisciplinary capability across: • NHS stakeholder engagement and pilot support; • sustainability and circular economy; • MedTech / innovative practice adoption; • quality improvement and benefits assessment; • behavioural insight and implementation barriers; • health economics; • data collection, evidence analysis and reporting; • IPC and patient safety input; • development of guidance, toolkits and recommendations. Estimated contract value The estimated maximum contract value is £463,520 excluding VAT (£556,224 including VAT). This comprises £213,520 excluding VAT for the initial two projects and up to £250,000 excluding VAT for additional in-scope activity.